File Download
  Patent History
  • Application
    US 12/913395 2010-10-27
  • Publication
    US 20110098264 2011-04-28
Supplementary

Patent: PHARMACEUTICAL COMPOSITION CONTAINING CYCLOMETALATED N-HETEROCYCLIC CARBENE COMPLEXES FOR CANCER TREATMENT

TitlePHARMACEUTICAL COMPOSITION CONTAINING CYCLOMETALATED N-HETEROCYCLIC CARBENE COMPLEXES FOR CANCER TREATMENT
Priority Date2010-10-27 US 12/913395
2009-10-28 US 12/255667P
2010-02-05 US 12/301752P
Inventors
Issue Date2011
Citation
US Published patent application US 20110098264. Washington, DC: US Patent and Trademark Office (USPTO), 2011 How to Cite?
AbstractThe present disclosure is related to a pharmaceutical composition for treatment of cancer comprising a cyclometalated N-heterocyclic carbene complex. The cyclometalated N-heterocyclic carbene complex contains a gold(III) or a platinum(II) atom. The pharmaceutical composition possesses anti-cancer activity such as the induction of cell death, inhibition of cellular proliferation, inhibition of topoisomerase and/or poisoning of topoisomerase.
Persistent Identifierhttp://hdl.handle.net/10722/206622
References

 

DC FieldValueLanguage
dc.date.accessioned2014-11-21T08:07:26Z-
dc.date.available2014-11-21T08:07:26Z-
dc.date.issued2011en_US
dc.identifier.citationUS Published patent application US 20110098264. Washington, DC: US Patent and Trademark Office (USPTO), 2011en_US
dc.identifier.urihttp://hdl.handle.net/10722/206622-
dc.description.abstractThe present disclosure is related to a pharmaceutical composition for treatment of cancer comprising a cyclometalated N-heterocyclic carbene complex. The cyclometalated N-heterocyclic carbene complex contains a gold(III) or a platinum(II) atom. The pharmaceutical composition possesses anti-cancer activity such as the induction of cell death, inhibition of cellular proliferation, inhibition of topoisomerase and/or poisoning of topoisomerase.en_US
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License for public patent documentsen_US
dc.titlePHARMACEUTICAL COMPOSITION CONTAINING CYCLOMETALATED N-HETEROCYCLIC CARBENE COMPLEXES FOR CANCER TREATMENTen_US
dc.typePatenten_US
dc.identifier.authorityCHE, CHI MING=rp00670en_US
dc.description.naturepublished_or_final_versionen_US
dc.contributor.inventorCHE, CHI MINGen_US
dc.contributor.inventorSUN, RAYMOND WAI-YINen_US
dc.contributor.inventorCHOW, LOK FUNGen_US
dc.contributor.inventorYAN, JINGen_US
patents.identifier.applicationUS 12/913395en_US
patents.description.assigneeUNIV HONG KONG [HK]en_US
patents.description.countryUnited States of Americaen_US
patents.date.publication2011-04-28en_US
dc.relation.referencesUS 2009110750 (A1) 2009-04-30en_US
patents.identifier.hkutechidChm-2009-00331-1en_US
patents.date.application2010-10-27en_US
patents.date.priority2010-10-27 US 12/913395en_US
patents.date.priority2009-10-28 US 12/255667Pen_US
patents.date.priority2010-02-05 US 12/301752Pen_US
patents.description.ccusen_US
patents.identifier.publicationUS 20110098264en_US
patents.relation.familyU S8530659 (B2) 2013-09-10en_US
patents.relation.familyCN 102741262 (A) 2012-10-17en_US
patents.relation.familyEP 2493896 (A1) 2012-09-05en_US
patents.relation.familyUS 2013324511 (A1) 2013-12-05en_US
patents.relation.familyWO 2011050574 (A1) 2011-05-05en_US
patents.description.kindA1en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats